瑞士医院的儿科病床容量:全面分析
Juliane Wurm1,2, Christoph Berger3, Vera Bernet4
1Department of Paediatrics, Fribourg Hospital, Fribourg, Switzerland.
Swiss medical weekly
|October 24, 2025
概括
全国一项调查显示,瑞士有1751张儿童医院病床,区域差异很大. 许多病床未经营,突出了对更好的医疗保健规划和为儿科服务收集数据的需求.
科学领域:
- 医疗保健管理的管理
- 儿科卫生服务 儿科卫生服务
- 瑞士医疗保健系统 瑞士医疗保健系统
背景情况:
- 瑞士的医疗保健系统将儿科医院基础设施分散到各州.
- 目前没有关于儿科医院病床的官方统计数据.
研究的目的:
- 通过在全国范围内收集和分析儿科医院病床信息来解决数据不足的问题.
- 提供瑞士儿科病床供应情况的全面概述.
主要方法:
- 在2023年1月进行了一项全国跨部门电子邮件调查.
- 关于结构上可用和经营的儿科病床的数据被收集并被描述性地分析.
主要成果:
- 在29个瑞士儿科医院/部门中,共确定了1751张床位,其中85%的床位是手术的.
- 112个是儿科重症监护病房床位 (80%的手术),339个是新生儿病房床位 (86%的手术).
- 在床与儿童比率方面观察到显著的区域差异,其中瑞士中部,瑞士东部和蒂西诺地区的比率较低.
结论:
- 该研究强调了当前儿科病床的分布,以及显著的非手术病床比例.
- 调查结果强调了持续,全面的数据收集对于有效的医疗保健规划的重要性.
- 解决儿科病床供应的区域差异对于公平获得医疗保健至关重要.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Distribution
251
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
251
Drug Dosing: Infants and Children
250
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
250
Pharmacokinetics in Pediatric Patients: Drug Excretion
209
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
209
Hospitals-I
1.5K
Hospitals offer medical and surgical care to the sick and injured, along with accommodation while they recover. At the same time, they also provide outpatient, emergency, psychiatric, and rehabilitation services to meet various community needs. In addition to providing medical care, hospitals also act as hubs for medical research and training. Hospitals use clinical procedures and evidence-based practice standards to deliver patient care. To deliver safe and efficient care, a nurse must stay up...
1.5K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
241
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
241
Pharmacokinetics in Pediatric Patients: Drug Metabolism
191
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
191


